|Bioavailability||up to 89%|
|Elimination half-life||25.4 hours (intravenous routes)|
|Chemical and physical data|
|Molar mass||60000–100000 g/mol|
Azoximer bromide is a macromolecular compound with high-molecular weight and not proved immunomodulating activity. It is using in CIS countries for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative. Azoximer bromide is sold under the trade name Polyoxidonium.
References[change | change source]
- http://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereof[permanent dead link]
- State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003